Author:
Chen Liqin,Zhang Wei,Hu Steven
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference24 articles.
1. Carcinogenicity categorization of chemicals −new aspects to be considered in a European perspective;Bolt;Toxicol. Lett.,2004
2. Regulating impurities in pharmaceutical products: a tolerability of risk approach?;Bouder;Expert Rev. Clin. Pharmacol.,2008
3. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity;Müller;Regul. Toxicol. Pharmacol.,2006
4. Guideline on the Limits of Genotoxic Impurities CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006;EMEA-CHMP,2006
5. Guidance for Industry: Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches (draft);USFDA,2008
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献